Skip to main content

Table 1 Characteristic details of patient

From: Treatment of the benign lytic lesions of the proximal femur with synthetic bone graft

No.

Age and gender

Diagnosis

Synthetic substitute

Internal fixation

Follow-up (months)

Operative time (min)

Complication

1

18/M

Residual SBC

HA

No

76

100

2

31/F

FD

β-TCP -HA

No

145

135

3

41/M

SBC

β-TCP

No

9

80

4

11/M

FD

β-TCP

No

57

140

5

28/M

EG

β-TCP

No

14

140

6

21/M

SBC

β-TCP

No

52

95

7

65/M

FD

β-TCP

No

42

215

8

22/M

CB

β-TCP

No

10

150

9

18/F

GCT

β-TCP

No

98

245

Recurrence

10

32/M

CB

β-TCP

No

127

95

11

16/M

CB

α-TCP

No

27

150

12

28/M

CB

β-TCP

DHS

144

210

13

6/M

SBC

β-TCP

No

30

82

14

22/F

SBC

α-TCP

No

64

100

15

6/M

Recurrent SBC

α-TCP

No

81

92

16

21/M

CB

α-TCP

No

35

156

17

24/M

Recurrent GCT

α-TCP

Screw

77

212

18

32/M

GCT

α-TCP

No

91

220

19

20/M

CB

α-TCP

No

26

131

20

15/M

Recurrent CB

α-TCP

No

39

157

21

12/M

FD

α-TCP

No

54

174

22

37/F

FD

α-TCP

No

41

141

23

36/M

FD

α-TCP

No

26

148

24

27/F

FD

α-TCP

No

38

115

25

16/M

SBC

α-TCP

No

33

114

Fracture

26

46/M

FD

β-TCP

DHS

27

123

27

38/M

SBC

α-TCP

No

10

139

  1. α-TCP alpha tricalcium phosphate, β-TCP beta tricalcium phosphate, CB chondroblastoma, DHS dynamic hip screw, EG eosinophilic granuloma, F female, FD fibrous dysplasia, GCT giant cell tumor, HA hydroxyapatite, M male, SBC simple bone cyst